ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
DSM has acquired food enzymes and oilseed processing businesses from San Diego-based Verenium for $37 million. The businesses are expected to post sales of $15 million this year. Included in the deal are licenses for α-amylase and xylanase enzymes for the food and beverage markets. For the oilseed processing market, DSM obtained Purifine, an enzyme that increases yield and makes processing less expensive. The businesses’ R&D portfolios and partnership agreements will transfer to DSM. Finally, DSM will have access to Verenium’s microbial biodiversity collection and library.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X